Skip to content
Screener

Black Diamond Therapeutics, Inc. BDTX Q2 2025 earnings

Reported August 7, 2025 · Before market open

EPS-$0.19Beat by $0.06
EPS estimate-$0.25

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$8.3M
EPS estimate-$0.06

FAQ

When did Black Diamond Therapeutics, Inc. report Q2 2025 earnings?
Black Diamond Therapeutics, Inc. (BDTX) reported Q2 2025 earnings on August 7, 2025 before market open.
What were Black Diamond Therapeutics, Inc.'s Q2 2025 revenue and EPS?
Black Diamond Therapeutics, Inc. reported eps of $-0.19 for Q2 2025.
Did Black Diamond Therapeutics, Inc. beat estimates in Q2 2025?
EPS beat the consensus estimate of $-0.25 by $0.06.
How did Black Diamond Therapeutics, Inc.'s Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 47.2% from $-0.36.
Where can I find Black Diamond Therapeutics, Inc.'s Q2 2025 SEC filings?
You can read the 8-K earnings release (0001701541-25-000029) and the 10-Q periodic report (0001701541-25-000030) directly on SEC EDGAR. The filing index links above go to sec.gov.